BIOVIE INC. Business Finance Contracts & Agreements
37 Contracts & Agreements
- Debenture Agreements (1 contract)
- Loan Agreements (2)
- Purchase Agreements (8)
- Registration Rights Agreements (3)
- Stock Agreements (2)
- Underwriting Agreements (4)
- Warrant Agreements (17)
- Form of Placement Agent's Warrant Agreement (included in Exhibit 10.1) (Filed With SEC on October 24, 2024)
- Form of Warrant (Filed With SEC on October 24, 2024)
- Form of Placement Agent's Warrant Agreement (included in Exhibit 10.1) (Filed With SEC on October 22, 2024)
- Form of Warrant (Filed With SEC on October 22, 2024)
- Form of Placement Agent's Warrant Agreement (included in Exhibit 10.1) (Filed With SEC on September 24, 2024)
- Form of Common Warrant (Filed With SEC on September 24, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on September 24, 2024)
- Form of Common Warrant (Filed With SEC on March 4, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on March 4, 2024)
- Amendment No. 2 to Asset Purchase Agreement, dated January 13, 2023, by and between BioVie Inc. and Acuitas Group Holdings, LLC, and Acuitas Group Holdings, LLC, solely for... (Filed With SEC on February 10, 2023)
- Amended and Restated Registration Rights Agreement, dated August 15, 2022, by and between BioVie Inc. and Acuitas Group Holdings, LLC (Filed With SEC on November 4, 2022)
- Securities Purchase Agreement, dated July 15, 2022, by and between the Company and Acuitas Group Holdings, LLC (Filed With SEC on July 18, 2022)
- Form of Common Stock Purchase Warrant (Filed With SEC on July 18, 2022)
- Securities Purchase Agreement, dated July 15, 2022, by and between the Company and Acuitas Group Holdings, LLC (Filed With SEC on July 15, 2022)
- Form of Common Stock Purchase Warrant (Filed With SEC on July 15, 2022)
- Form of Warrant to Purchase Shares of Class A Common Stock of BioVie Inc (Filed With SEC on December 1, 2021)
- Supplement to Loan and Security Agreement, dated November 30, 2021, among BioVie Inc., Avenue Venture Opportunities Fund II, L.P. and Avenue Venture Opportunities Fund, L.P (Filed With SEC on December 1, 2021)
- Loan and Security Agreement, dated November 30, 2021, among BioVie Inc. Avenue Venture Opportunities Fund II, L.P., and Avenue Venture Opportunities Fund, L.P (Filed With SEC on December 1, 2021)
- Underwriting Agreement between the Company and ThinkEquity, a division of Fordham Financial Management, Inc., as representatives of the several Underwriters, dated August 8, 2021 (Filed With SEC on August 11, 2021)
- Registration Rights Agreement, dated June 10, 2021, by and between the Company and Acuitas Group Holdings, LLC (Filed With SEC on June 11, 2021)
- Amendment No. 1 to Asset Purchase Agreement, dated May 9, 2021, by and among the Company, NeurMedix, Inc. and Acuitas Group Holdings, LLC (Filed With SEC on May 10, 2021)
- Asset Purchase Agreement, dated April 27, 2021, by and among the Company, NeurMedix, Inc. and Acuitas Group Holdings, LLC (Filed With SEC on April 27, 2021)
- Form of Underwriting Agreement (Filed With SEC on September 8, 2020)
- Form of Placement Agency Agreement (including form of Placement Agent Warrant) (Filed With SEC on March 11, 2020)
- Amendment to Securities Purchase Agreement, dated as of October 9, 2019, by and between BioVie Inc. and Acuitas Group Holdings, LLC (Filed With SEC on October 9, 2019)
- Form of Common Stock Purchase Warrant (Filed With SEC on October 9, 2019)
- Form of Underwriting Agreement (Filed With SEC on October 4, 2019)
- Warrant Agency Agreement and Form of Warrant offered hereby (Filed With SEC on October 2, 2019)
- Securities Purchase Agreement dated as of September 24, 2019 (Filed With SEC on September 25, 2019)
- Form of Common Stock Purchase Warrant (Filed With SEC on September 25, 2019)
- Form of 10% OID Convertible Delayed Draw Debenture (Filed With SEC on September 25, 2019)
- Form of Underwriting Agreement (Filed With SEC on August 8, 2019)
- Specimen Certificate representing shares of Class A Common Stock (Filed With SEC on April 30, 2019)
- Securities Purchase Agreement, dated as of July 3, 2018, by and among BioVie Inc., Acuitas Group Holdings, LLC and the Purchasers identified therein (Filed With SEC on July 3, 2018)
- Form of Common Stock Purchase Warrant (Filed With SEC on July 3, 2018)
- Common Stock Purchase Agreement, dated January 4, 2017 between BIOVIE, INC. and Aspire Capital Fund, LLC (Filed With SEC on January 5, 2017)
- Registration Rights Agreement, dated January 4, 2017, between BIOVIE, INC. and Aspire Capital Fund, LLC (Filed With SEC on January 5, 2017)
